Join us on May 21st for our 2025 Global Chemical Processing Project Spending Outlook! RSVP Today!
Sales & Support: +1 800 762 3361
Member Resources
Novartis Opens Cell and Gene Therapy Plant in Switzerland

GALWAY, IRELAND--December 11, 2019--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Novartis International AG (NYSE:NVS) (Basel, Switzerland) has inaugurated a new $90 million pharmaceutical plant in Stein, Switzerland, that will focus on gene and cell therapies. Within this article: Details new plant opening, investment, gene and cell therapies focus, potential site for future Kymriah manufacture

Login or Register for Instant Access

Subscribe Now!

(All Fields Required)

IIR Logo Globe

Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.

×
×
Contact Us

For More Info!